Bio-gate AG (BIG1) — Working Capital to Net Assets Ratio
Bio-gate AG (BIG1) has a Working Capital to Net Assets ratio of 66.9% as of December 2024. Working capital of €1.20 Million (current assets of €2.25 Million minus current liabilities of €1.06 Million) is measured against net assets of €1.79 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BIG1 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bio-gate AG Working Capital to Net Assets (2020–2024)
This chart shows how Bio-gate AG's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of December 2024, the ratio stands at 66.9%, reflecting working capital of €1.20 Million against net assets of €1.79 Million EUR. For the complete balance sheet picture, see Bio-gate AG balance sheet assets.
Annual Working Capital to Net Assets for Bio-gate AG (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bio-gate AG from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Bio-gate AG (BIG1) total liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 66.9% | €1.20 Million | €1.79 Million | €2.25 Million | €1.06 Million | ▼ -2.6 pp |
| 2023 | 69.5% | €2.40 Million | €3.45 Million | €3.37 Million | €967.87K | ▼ -1.5 pp |
| 2022 | 71.0% | €3.02 Million | €4.25 Million | €4.21 Million | €1.19 Million | ▼ -2.3 pp |
| 2021 | 73.4% | €2.77 Million | €3.77 Million | €3.60 Million | €832.26K | ▲ +13.9 pp |
| 2020 | 59.5% | €922.21K | €1.55 Million | €2.04 Million | €1.12 Million | — |